Arizona

The Board of Pharmacy will meet on June 19 and 20. Visit the Board’s website in advance to review the agenda.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-06-06T16:09:26-04:00June 6, 2024|Arizona|

Arizona

Gov. Katie Hobbs (D) signed HB (House Bill) 2582 (Chapter 123), legislation permitting pharmacists to enter into collaborative practice agreements with a state-licensed certified nurse midwife or a physician assistant.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-05-09T11:50:54-04:00May 9, 2024|Arizona|

Arizona

On March 29, Gov. Katie Hobbs (D) signed SB 1165 (Chapter 51), legislation outlining specified provisions an auditing entity must comply with when conducting a wholesale invoice audit and prohibits an auditing entity from retroactively reducing the amount of a claim unless specified criteria apply.  

Also in Arizona, on April 2, Gov. Katie Hobbs (D) signed SB 1021, legislation removing the requirement that health professional groups proposing to increase the scope of practice of a state-regulated health profession must complete a statutory sunrise review. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-05-08T17:14:10-04:00April 4, 2024|Arizona|

Arizona

On March 6, upon reconsideration, the Senate failed to pass SB 1085 by one vote. This bill would have authorized pharmacists to test and initiate treatment for conditions such as influenza, COVID, strep and other respiratory illnesses and to delegate the administrative and technical tasks of performing a test to a trained member of the pharmacy staff who is under the supervision of the pharmacist. 

Also in Arizona, this week, the Department of Health Services (ADHS) launched a naloxone campaign aimed at combating the state’s opioid overdose crisis. This multi-media campaign features stories from a diverse group of Arizonans whose lives were impacted by naloxone, connects those with substance use disorder to support resources, and demonstrates how to use naloxone to save lives. The FDA-approved injectable and nasal spray formulations are available over the counter, at pharmacies, community-based distribution programs, and through local health departments, making it possible for the public to also utilize naloxone to save lives. The ADHS encourages individuals to get it without a prescription at your local pharmacy.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-03-21T12:11:45-04:00March 21, 2024|Arizona|

Arizona

The following bills will be heard in the House Regulatory Affairs Committee on March 13:  

  • SB 1164, legislation prohibiting PBMs (Pharmacy Benefit Managers) from limiting or excluding coverage of a prescription drug for any covered individual who is on a specific prescription drug when certain conditions are met; prescribing formulary change notification requirements; and establishing a prescription coverage exemption determination process. 
  • SB 1165, legislation prohibiting an auditing entity from retroactively reducing the amount of a claim payment to a pharmacist or pharmacy after adjudication of the claim for a prescription drug, with certain exceptions and prescribes requirements for a wholesale invoice audit. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-03-08T11:38:07-05:00March 8, 2024|Arizona|

Arizona

On February 21, the Senate Committee of the Whole (COW) adopted an amendment to SB 1085 (Senate Engrossed). The bill failed the third reading in the Senate on February 22.  Senate President Warren Petersen (R) offered a Motion to Reconsider.

Also in Arizona, SB 1021 (Senate Engrossed), repealing the Sunrise process for expansion of scope of practice for a “health professional group”, was adopted by the Senate with a vote of 24-4-2. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-02-23T10:36:37-05:00February 23, 2024|Arizona|
Go to Top